Osei-Gyimah P, Piascik M T, Fowble J W, Feller D R, Miller D D
J Med Chem. 1978 Nov;21(11):1173-8. doi: 10.1021/jm00209a019.
The synthesis and pharmacological activity of erythro and threo isomers of 1-(3',4',5'-trimethoxy-alpha-hydroxy-benzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, 2 and 3, are reported. The structural assignments of 2 and 3 are based upon NMR spectra of the 6,7-dibenzyl precursors, 6 and 10, and of the synthetic derivatives of 13alpha- and 13beta-hydroxy-2,3-(dibenzyloxy)-9,10,11-trimethoxytetrahydroprotoberberine, 8 and 12, respectively. The erythro isomer 2 was a more potent beta-adrenoceptor stimulant than the threo isomer 3 in guinea pig atrial, guinea pig tracheal, and rat adipocyte preparations. The differential activity of these compounds on lipolysis was favorably correlated to changes in the stimulation of adenylate cyclase activity and cAMP accumulation in rat adipocytes.
报道了1-(3',4',5'-三甲氧基-α-羟基-苄基)-6,7-二羟基-1,2,3,4-四氢异喹啉(2和3)的赤型和苏型异构体的合成及其药理活性。2和3的结构归属是基于6,7-二苄基前体6和10以及分别为13α-和13β-羟基-2,3-(二苄氧基)-9,10,11-三甲氧基四氢原小檗碱的合成衍生物8和12的核磁共振谱。在豚鼠心房、豚鼠气管和大鼠脂肪细胞制剂中,赤型异构体2作为β-肾上腺素能受体激动剂比苏型异构体3更有效。这些化合物在脂解作用上的差异活性与大鼠脂肪细胞中腺苷酸环化酶活性刺激和环磷酸腺苷积累的变化呈良好的相关性。